Complementary and alternative medicine use in patients with gynecological cancers in Europe

被引：42
作者：
Molassiotis, A
Browall, M
Milovics, L
Panteli, V
Patiraki, E
Fernandez-Ortega, P
机构：
[1] Univ Manchester, Sch Nursing, Manchester M13 9PL, Lancs, England
[2] Sahlgrenska Univ Hosp, Gothenburg, Sweden
[3] Inst Oncol & Radiol, Dept Educ, Belgrade, Serbia Monteneg
[4] Greek Oncol Nursing Soc, Athens, Greece
[5] Inst Catala Oncol ICO, Barcelona, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2006年 / 16卷
关键词：
alternative medicine; complementary medicine; complementary therapies; gynecological cancer;
D O I：
10.1111/j.1525-1438.2006.00309.x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The aim of the present study was to assess the use of complementary and alternative medicine (CAM) specifically in women with gynecological cancer. The design of the study was of a descriptive cross-sectional survey using a 27-item questionnaire. The study was conducted in 11 countries in Europe as part of a larger project. Data were available from 72 gynecological cancer patients. Among the participants, 40.3% used CAM after the diagnosis with cancer. The most popular CAM modalities used were herbal medicine (34.5%), relaxation techniques (21.4%), and vitamins/minerals (20.7%). A very high level of satisfaction with CAM use was reported. Patients used CAM to increase the body's ability to fight the cancer or to improve physical and emotional well-being. The main sources of information about CAM were informal (friends/ family or the media). It is important to discuss CAM use with gynecological cancer patients, as they frequently use it and such use may have implications for clinical practice.
引用
收藏
页码：219 / 224
页数：6
相关论文
共 23 条
[11]  
Kiefer D, 2001, ALTERN THER HEALTH M, V7, P74
[12]   Choice of unconventional treatment by patients with cancer [J].
Kimby, CK ;
Launso, L ;
Henningsen, I ;
Langgaard, H .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2003, 9 (04) :549-561
[13]   Use of complementary and alternative medicine in cancer patients: a European survey [J].
Molassiotis, A ;
Fernandez-Ortega, P ;
Pud, D ;
Ozden, G ;
Scott, JA ;
Pantelil, V ;
Margulies, A ;
Browall, M ;
Magri, M ;
Selvekerova, S ;
Madsen, E ;
Milovics, L ;
Bruyns, I ;
Gudmundsdottir, G ;
Hummerston, S ;
Ahmad, AMA ;
Platin, N ;
Kearney, N ;
Patiraki, E .
ANNALS OF ONCOLOGY, 2005, 16 (04) :655-663
[14]   Quality and safety issues of web-based information about herbal medicines in the treatment of cancer [J].
Molassiotis, A ;
Xu, M .
COMPLEMENTARY THERAPIES IN MEDICINE, 2004, 12 (04) :217-227
[15]   An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies [J].
Navo, MA ;
Phan, J ;
Vaughan, C ;
Palmer, JL ;
Michaud, L ;
Jones, KL ;
Bodurka, DC ;
Basen-Engquist, K ;
Hortobagyi, GN ;
Kavanagh, JJ ;
Smith, JA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) :671-677
[16]   Types of alternative medicine used by patients with breast, colon, or prostate cancer: Predictors, motives, and costs [J].
Patterson, RE ;
Neuhouser, ML ;
Hedderson, MM ;
Schwartz, SM ;
Standish, LJ ;
Bowen, DJ ;
Marshall, LM .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2002, 8 (04) :477-485
[17]   Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology [J].
Richardson, MA ;
Sanders, T ;
Palmer, JL ;
Greisinger, A ;
Singletary, SE .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) :2505-2514
[18]   The patient's motivation in seeking complementary therapies [J].
Ritvo, P ;
Irvine, J ;
Katz, J ;
Matthew, A ;
Sacamano, J ;
Shaw, BF .
PATIENT EDUCATION AND COUNSELING, 1999, 38 (02) :161-165
[19]   Use of complementary/alternative therapies by women with advanced-stage breast cancer [J].
Shen J. ;
Andersen R. ;
Albert P.S. ;
Wenger N. ;
Glaspy J. ;
Cole M. ;
Shekelle P. .
BMC Complementary and Alternative Medicine, 2 (1)
[20]   Use of complementary and alternative medicine among women with gynecologic cancers [J].
Swisher, EM ;
Cohn, DE ;
Goff, BA ;
Parham, J ;
Herzog, TJ ;
Rader, JS ;
Mutch, DG .
GYNECOLOGIC ONCOLOGY, 2002, 84 (03) :363-367
123